Upcoming AWS Coverage on Quintiles IMS Holdings Post-Earnings Results
LONDON, UK / ACCESSWIRE / November 15, 2016 / Active Wall St. announces its post-earnings coverage on PerkinElmer Inc. (NYSE: PKI). The company reported its financial results for the third quarter fiscal 2016 (Q3 FY16) on November 07, 2016. The Waltham, Massachusetts-based company's GAAP gross margin and adjusted gross margin expanded 240 and 170 basis points, respectively. Register with us now for your free membership at: http://www.activewallst.com/register/.
One of PerkinElmer's competitors within the Medical Laboratories & Research space, Quintiles IMS Holdings, Inc. (NYSE: Q), reported ON November 02, 2016, financial results for the quarter ended September 30, 2016 for Quintiles Transnational Holdings, Inc. on a standalone basis. AWS will be initiating a research report on Quintiles IMS in the coming days.
Today, AWS is promoting its earnings coverage on PKI; touching on Q. Get our free coverage by signing up to:
For the three months ended on October 02, 2016, PerkinElmer reported revenues of $548.05 million which came in below $563.44 million recorded at the end of Q3 FY15. Total revenues for the reported quarter also fell short of market expectations of $572 million. The company recorded a negative organic growth of 2% during Q3 FY16. Furthermore, adjusted revenue for the reported quarter came in at $548.23 million compared to $563.60 million in Q3 FY15.
The healthcare instruments company reported Q3 FY16 GAAP net income from continuing operations of $57.75 million, or $0.52 per diluted share, compared to $54.90 million, or $0.48 per diluted share, in Q3 FY15. The company's adjusted earnings for Q3 FY16 came in at $0.68 per diluted share, which was above $0.60 per diluted share reported in the prior year's period and market earnings estimates of $0.66 per diluted share.
In Q3 FY16, the company posted GAAP operating income from continuing operations of $81.23 million compared to $75.90 million in past year period. Operating profit margin for Q3 FY16 was 14.8% of revenue versus 13.5% of revenue in the year ago quarter.
Adjusted operating income for Q3 FY16 stood at $103.88 million as compared to $95.73 million in the previous year's same period. Furthermore, adjusted operating profit margin for Q3 FY16 was 18.9% of adjusted revenue compared to 17.0% of adjusted revenue in Q3 FY15.
During Q3 FY16, Human Health segment revenue came in at $338.24 million, down 2% from $343.63 million in the year ago period. During the quarter, organic revenue growth was flat, impacted by the extra week in the comparable prior period. The segment reported Q3 FY16 operating income of $64.56 million compared to $63.15 million in Q3 FY15. However, Human Health segment operating profit margins rose to 19.1% of segment revenue in Q3 FY15 from 18.4% of segment revenues in Q3 FY15.
PerkinElmer's Environmental Health segment revenues were $209.81 million in Q3 FY16, which was 5% less than last year's recorded revenues of $219.80 million. During the quarter, the segment's organic revenue declined 5% due to softer capital equipment end markets. The segment reported operating income of $27.66 million versus $22.84 million in Q3 FY15. Additionally, operating profit margin improved to 13.2% of segment revenue in Q3 FY16 from 10.4% of segment revenues inn Q3 FY15.
Cash Flow & Balance Sheet
In the reported quarter, PerkinElmer generated $73.24 million in cash from operations of continuing operations compared to $60.77 million in the year ago quarter. The company had cash and cash equivalents balance of $311.66 million as on October 02, 2016, compared to $237.93 million at the close of books on January 03, 2016. Furthermore, the company ended the quarter with long-term debt of $1.13 billion compared to $1.01 billion as on January 03, 2016.
In a separate press release on October 26, 2016, PerkinElmer's Board of Directors declared a quarterly cash dividend of $0.07 per common share, payable on February 10, 2017, to shareholders of record at the close of business on January 20, 2017.
For full FY16, PerkinElmer narrowed its previous guidance of GAAP earnings per share from continuing operations to a new range of $2.24 to $2.26. Furthermore, on a non-GAAP basis (expected to include certain adjustments), adjusted earnings is projected to be $2.75 per share to $2.77 per share.
At the close of trading session on November 14, 2016, PerkinElmer's stock price slipped 1.24% to end the day at $50.27. A total volume of 976.01 thousand shares were exchanged during the session, which was above the 3-month average volume of 604.54 thousand shares. The stock currently has a market cap of $5.45 billion and is trading at a PE ratio of 23.73.
Active Wall Street:
Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
AWS has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active Wall Street